Management of cancer pain

被引:1
作者
de Wit, Maike [1 ]
机构
[1] Univ Klinikum Hamburg Eppendorf, Med Klin 2, D-20246 Hamburg, Germany
来源
CHIRURGISCHE GASTROENTEROLOGIE | 2007年 / 23卷 / 01期
关键词
cancer pain; pain management; analgetics; chronic pain;
D O I
10.1159/000097481
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
About 50 - 80% of all cancer patients experience pain which is due to different reasons, originated at different locations, and showed different levels of intensity. Sometimes the pain is not provoked by the tumor itself but is due to other causes, e. g. disk prolaps. However, normally the pain is caused by the tumor or the metastases. Specialized methods of cancer treatment such as surgery, radiation or chemotherapy provide the most efficient and direct approaches to relieve the patients from their pain. However, this approach normally needs more time than symptomatic pain management. Adequate symptomatic therapy of cancer pain given as transient or permanent treatment leads to rapid pain relief. Based on the type and location of pain, the underlying cause of pain is diagnosed and the most suitable treatment regime is chosen. Basic rules of medical pain therapy according to the WHO pain relief ladder, the regular intake of medicines and a pain survey with individual dose adjustment should be observed. Co-medication with antiemetics and laxatives should also be initiated to prevent side effects such as nausea and constipation. Co-analgetics such as anticonvulsants to relief neuropathic pain should be given early. Pain is always a multidimensional problem, and an interdisciplinary approach should be an integral part of care in cancer patients including not only adequate pain medication but also physical therapy as well as psychological and social support.
引用
收藏
页码:30 / 37
页数:8
相关论文
共 31 条
  • [1] THE MULTIDIMENSIONAL NATURE OF CANCER-RELATED PAIN
    AHLES, TA
    BLANCHARD, EB
    RUCKDESCHEL, JC
    [J]. PAIN, 1983, 17 (03) : 277 - 288
  • [2] PAIN CAUSES IN 200 PATIENTS REFERRED TO A MULTIDISCIPLINARY CANCER PAIN CLINIC
    BANNING, A
    SJOGREN, P
    HENRIKSEN, H
    [J]. PAIN, 1991, 45 (01) : 45 - 48
  • [3] Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO
  • [4] 2-0
  • [5] Brema F, 1996, INT J CLIN PHARM RES, V16, P109
  • [6] Methadone versus morphine as a first-line strong opioid for cancer pain: A randomized, double-blind study
    Bruera, E
    Palmer, JL
    Bosnjak, S
    Rico, MA
    Moyano, J
    Sweeney, C
    Strasser, F
    Willey, J
    Bertolino, M
    Mathias, C
    Spruyt, O
    Fisch, MJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) : 185 - 192
  • [7] Gabapentin for neuropathic cancer pain: A randomized controlled trial from the gabapentin cancer pain study group
    Caraceni, A
    Zecca, E
    Bonezzi, C
    Arcuri, E
    Tur, RY
    Maltoni, M
    Visentin, M
    Gorni, G
    Martini, C
    Tirelli, W
    Barbieri, M
    De Conno, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 2909 - 2917
  • [8] PAIN AND ITS TREATMENT IN OUTPATIENTS WITH METASTATIC CANCER
    CLEELAND, CS
    GONIN, R
    HATFIELD, AK
    EDMONSON, JH
    BLUM, RH
    STEWART, JA
    PANDYA, KJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) : 592 - 596
  • [9] Coyle N, 1990, J Pain Symptom Manage, V5, P83
  • [10] DAUT RL, 1983, CANCER, V50, P1913